|
| [November 15, 2012] |
 |
Research and Markets: Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/vwfkkw/active)
has announced the addition of the "Active
Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in
Developing Markets to Come From Cost Efficient Manufacturing and Rising
Domestic Demand" report to their offering.
GBI Research's report, Active Pharmaceutical Ingredients (API) Global
Market to 2017 - Growth in Developing Markets to Come From Cost
Efficient Manufacturing and Rising Domestic Demand provides detailed
insight into the global APIs market. The research presents detailed
analysis and forecasts of the major economic and market trends affecting
the global APIs market.
The report contains market forecasts, product type analysis, and drivers
and restraints for growth. In addition, it includes therapeutic category
analysis and contract manufacturing organizations' (CMO) growth in the
region, and their influence on PI manufacturing activity towards 2017.
Overall, the report presents a comprehensive analysis of the global APIs
market, covering all the major parameters.
The report is built using data and information sourced from proprietary
databases, primary and secondary research and in-house analysis by GBI
Research's team of industry experts.
The global APIs market was dominated by North America, which generated
35.1% of global API revenues in 2011. The Asia-Pacific region also saw
high growth, second behind North America with a revenue share of 29.7%
in 2011.
The global APIs market revenues reached $108,613m in 2011. In the
product-based segments, the synthetic market dominated the market with
82.7% of global APIs revenues.
However, increasing acceptance and increasing penetration are boosting
the biopharmaceuticals drug market in both developed and developing
economies.
Scope
- Market revenue data for APIs from 2005 to 2011, forecast forward for
six years to 2017.
- API markets in the regions of North America, Asia-Pacific and Europe,
along with key countries such as the US, Canada, Japan, China, South
Korea, India, Italy, Germany, France, the UK and Spain.
- API industry structure and market trends, such as a shift in
manufacturing and growth in biotechnology globally.
- Drivers and restraints for the global APIs market.
- Detailed historical, forecast trend and share analysis of API revenues
based on product types (synthetic and biotechnology APIs) at the global,
regional and key country levels.
- Detailed historical and forecast trends and share analysis for API
revenues based on the customer base (generic and innovative for
synthetic APIs, biosimilars and biologics for biotech APIs) at the
global, regional and key country levels.
- Analysis of API revenues based on therapeutic categories at a global
and regional level.
For more information visit http://www.researchandmarkets.com/research/vwfkkw/active
[ InfoTech Spotlight's Homepage ]
|
